This Article Full Text (PDF) All Versions of this Article: 0269881108093840v1 23/8/937    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Liu, Y. Articles by Lane, H. PubMed PubMed Citation Articles by Liu, Y. Articles by Lane, H. Social Bookmarking                         What's this?

Lack of association between AKT1 variances versus clinical manifestations and social function in patients with schizophrenia

Department of Psychiatry, Shinyin Hospital, Department of Health, Executive Yuan, Tainan, Taiwan

CL Huang

Department of Psychiatry, China Medical University and Hospital, Taichung, Taiwan

PL Wu

Department of Psychiatry, China Medical University and Hospital, Taichung, Taiwan

YC Chang

Institute of Life Sciences and Department of Mathematics, Tamkang University, Taipei, Taiwan

CH Huang

Department of Psychiatry, China Medical University and Hospital, Taichung, Taiwan

HY Lane

Department of Psychiatry and Institute of Clinical Medical Science, China Medical University and Hospital, Taichung, Taiwan, hylane{at}gmail.com

The elucidation of genotype-phenotype relationships in psychiatric research is at an early stage. V-akt murine thymoma viral oncogene homolog 1 (AKT1) is a serine/threonine kinase known as protein kinase B. Emerging studies have implicated the role of AKT1 in pathogenesis of schizophrenia; however, the findings have not been consistent. This study aims to examine the association of AKT1 polymorphisms with drug-free and post-treatment symptomatology and social function in patients with schizophrenia. One hundred and twenty newly hospitalised patients with acutely exacerbated schizophrenia who had never been treated by atypical antipsychotics were recruited. They received optimal treatment of risperidone for up to 42 days in the inpatient research unit. Clinical manifestations were monitored by Positive and Negative Syndrome Scale (PANSS) and social function by Nurses’ Observation Scale for Inpatients Evaluation (NOSIE). Patients were genotyped for eight AKT1 Single Nucleotide Polymorphism (SNPs), which have been previously investigated for association with schizophrenia. At drug-free status and after best possible treatment of risperidone, genotypes of each SNP did not influence performances in NOSIE, PANSS-total, -positive, -negative and -general psychopathology profiles. These results suggest that AKT1 does not play a significant role in clinical and functional manifestations in patients with schizophrenia who receive risperidone treatment. Future research should also focus on the relationships between genotypes of other susceptibility genes and phenotypes or functional outcomes of schizophrenia.

Key Words: AKT • antipsychotics • negative symptoms • positive symptoms • social function

This version was published on November 1, 2009

Journal of Psychopharmacology, Vol. 23, No. 8, 937-943 (2009)
DOI: 10.1177/0269881108093840


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?